Core Insights - Xiamen has focused on leveraging technological innovation to drive high-quality economic development over the past five years, implementing a series of initiatives to create a world-class innovation and entrepreneurship ecosystem [1] Group 1: Technological Innovation and Investment - During the "14th Five-Year Plan" period, Xiamen aims to deeply integrate technological and industrial innovation, achieving a systematic enhancement in comprehensive competitiveness [2] - The intensity of R&D expenditure in Xiamen increased from 3.08% in 2020 to 3.46% in 2024, surpassing the national average by 0.77 percentage points, with annual growth in corporate R&D spending exceeding 13% [2] - The number of high-value invention patents per 10,000 people reached 29.5, doubling compared to the end of the "13th Five-Year Plan" [2] Group 2: Innovation Ecosystem Development - Xiamen has established a comprehensive service system for innovation, including new R&D institutions, verification centers, and incubators, with over 2,500 new enterprises and R&D institutions added in core parks [2] - The Xiamen Torch High-tech Zone ranked 14th nationally in the first comprehensive evaluation by the Ministry of Industry and Information Technology [2] Group 3: Strategic Emerging Industries - The total scale of four major pillar industry clusters, including electronic information and machinery, exceeds 20 trillion yuan, while four strategic emerging industries, such as biomedicine and new energy, exceed 500 billion yuan [3] - The output value of strategic emerging industries accounts for over 40% of the total industrial output value, with high-tech manufacturing value-added growing by 18.7% year-on-year from January to August this year [3] Group 4: Policy and Institutional Reforms - Xiamen has deepened institutional reforms, promoting the integration of innovation, industry, finance, and talent, enhancing the vitality of various innovation entities [4] - The city has established a 5 billion yuan venture capital fund for technological innovation and expanded the technology innovation fund to 50 billion yuan, introducing innovative financial products to support enterprise development [4] Group 5: International Collaboration - Xiamen actively integrates into national and global innovation networks, establishing collaboration with 45 institutions from 11 countries, resulting in 138 cooperative projects [4] - The international scientific program on marine negative emissions has gathered 104 institutions from 35 countries, accelerating the aggregation of global innovation resources in Xiamen [4]

交流会上，无锡市药物临床试验机构联盟揭牌成立，2025年首批生物医药创新产品目录正式发布，无锡 新一代互联网医院同步上线。多位院士专家现场就医学科技创新前沿与成果转化应用作专题分享。 据悉，无锡已累计获批3个一类创新药、8个二类和三类创新医疗（002173）器械，近三年支持医工结合 项目31个，连续两年入选中国生物医药产业发展指数20强城市，生物医药集群获批国家先进制造业集 群。目前，该市正加快推进《无锡生物医药全产业链开放创新发展实施方案》和《无锡高新区生物医药 产业发展规划(2025-2030年)》编制工作。 由国联人寿主承保的2026年"医惠锡城"新产品暨"一键e赔"功能同步上线，推出创新药械纳入保障、增 加DRG除外责任等多项服务，进一步减轻群众就医负担。为进一步推动"创新药进医院、科研成果转 化"，无锡市国联健康基金会正式成立，首期募集资金3000万元。基金会现场向首批资助的市人民医院 胃癌早筛、江大附院核素药物转化两个科研项目进行捐赠。 中证报中证网讯(王珞)9月30日，无锡市医疗健康"产医研融合"创新成果交流会举行。现场，无锡市与 国家癌症中心签署新一轮深化合作协议，双方将共同深入开展全民癌症防 ...

近日，第七届中国制药工业博览会（药博会）在苏州工业园区举办，《2025年中国创新药企排名 TOP101榜单》发布。园区20家企业上榜，彰显了在国内创新药领域的实力。 该榜单从市值、业绩、研发管线以及商业化、研发投入、孵化等多维度综合评估，严选最具创新实 力与发展前景的药企，客观映射中国创新药头部势力版图。其中，信达生物、基石药业、开拓药业、亚 盛医药等20家园区企业荣耀登榜。 园区2006年重点布局生物医药及大健康产业以来，重点围绕创新药、高端医疗器械、大健康3大重 点领域，着力集聚创新资源要素，集聚相关企业超2000家，去年实现产值1655亿元。在创新药领域，今 年园区已有6款一类创新药获批上市，占全国同期新增约20%，展示了园区在全国生物医药领域的领先 地位和核心竞争力。 据了解，下一步，园区将持续营造技术创新、产业创新、协同创新齐头并进的良好局面，加大产业 扶持力度，助推更多创新企业发展壮大，全力打造国际一流生物医药创新策源地、世界级生物医药产业 地标核心区。 ...